Mesoblast Limited (ASX:MSB) Gains US FDA Clearance For Phase 2 Trial Of NeoFuse In Minimally Invasive Lumbar Spinal Fusi

  Melbourne, Australia, Aug 17, 2009 - (ABN Newswire) - Australian regenerative medicine company, Mesoblast Limited (ASX:MSB)(PINK:MBLTY), today announced that it has received clearance from the United States Food and Drug Administration (US FDA) for a Phase 2 clinical trial of its allogeneic or & quot;off-the-shelf & quot; adult stem cells in minimally invasive lumbar spinal fusion surgery.  

Sydney

  [ Change ]
 
Today

Min: 12°
Max: 19°
Possible afternoon shower.
Tomorrow

Min: 12°
Max: 19°
Possible afternoon shower.
 

Account

Login

To access your account and listings



Remember me
   
   
   
 
 
Find Hunter Valley accommodation online